Market Cap 1.34B
Revenue (ttm) 75.62M
Net Income (ttm) -72.70M
EPS (ttm) N/A
PE Ratio 66.75
Forward PE N/A
Profit Margin -96.14%
Debt to Equity Ratio 0.00
Volume 751,200
Avg Vol 1,710,834
Day's Range N/A - N/A
Shares Out 65.12M
Stochastic %K 19%
Beta 1.60
Analysts Strong Sell
Price Target $33.80

Company Profile

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of i...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 949 2643
Address:
321 Harrison Avenue, Suite 900, Boston, United States
juice_rock
juice_rock Jan. 30 at 5:50 PM
$GLUE About 82% institutional owned and almost 100% long. https://fintel.io/so/us/glue I see every reason to continue holding long term.
0 · Reply
LabPsycho
LabPsycho Jan. 28 at 3:57 PM
$GLUE @dylirious CEOs selling rarely is a good look. But I will give him a pass due to 500% gain in the stock in a few months and closing a great deal. But it , plus the large offering likely will put a damper on the stock and suggests to me nothing major is going to unfold in the next few months. I expect the stock to do a significant retrace before possibly climbing to $30 but that's many months away and a lot will happen in the overall market before then is my guess. As I have posted before I am thinking GLUE could be between 10 and 30 over the next year. The "executive sells are predetermined" is a great argument investors use to gaslight themselves to ignore the likely future trend of the stock. Good luck
0 · Reply
juice_rock
juice_rock Jan. 26 at 4:20 PM
$GLUE Will continue holding. $1.75 Billion market cap with $10 Billion in signed agreements upon milestones. And the last two interims are good data.
0 · Reply
JFais
JFais Jan. 23 at 1:09 PM
This week in Chat: -A number of interesting setups shared in our Non-Biotech channel, including Crypto & Tokenization side of things -Good back and forth on $CRVS, quite a few people owned into the data (vs selling early like I did 🤦‍♂️). Implications for evolving atopic dermatitis landscape & increased market penetration estimates (IF data holds up in higher N of patients). Not to mention impact on confidence level into pivotal PTCL readout and potential to soon move forward in expansion indications like asthma & HS). IP to 2042= long-lived per CEO but others think it's only to 2037 (plenty of time to develop soquelitinib in other indications as well as move next-gen ITK inhibitors forward) Also, noteworthy discussions in $GLUE, $CELC, $VIR, $AVBP among others
0 · Reply
oneyedjacks
oneyedjacks Jan. 22 at 8:52 PM
$GLUE Low volume day, but damn
0 · Reply
MuchMillions
MuchMillions Jan. 22 at 7:21 PM
$GLUE most likely sideways until the conference late February
0 · Reply
nbkihy8
nbkihy8 Jan. 22 at 3:54 PM
$GLUE I'm expecting the next leg up will happen these next few weeks. Prepare for $30 plus
0 · Reply
JFais
JFais Jan. 21 at 9:37 PM
Speaking of missed binaries $WVE $CRVS As well as blow-ups or stocks that ran without us (seeing $GLUE & $ERAS among those currently discussed in Chat) Was one reason I recorded video below (too many ppl being too hard on themselves vs simply live & learn, apply going forward)
0 · Reply
oneyedjacks
oneyedjacks Jan. 21 at 7:28 PM
$GLUE can anyone see this beyond the pay wall?1 https://finance.yahoo.com/m/03c3bd97-33c1-3e5b-b7d1-ef399f0928fc/staar-surgical-alumis-and.html
0 · Reply
Eroc
Eroc Jan. 21 at 3:54 PM
$GLUE I'm ready for the next leg up! Let's go bulls!
0 · Reply
Latest News on GLUE
Why Is Monte Rosa Stock Trading Higher Today?

Dec 16, 2025, 2:37 PM EST - 7 weeks ago

Why Is Monte Rosa Stock Trading Higher Today?


Monte Rosa: Looking Mispriced After Big Pharma Validation

Nov 30, 2025, 4:36 AM EST - 2 months ago

Monte Rosa: Looking Mispriced After Big Pharma Validation


This Biotech Stock Has Doubled Its Value Today—Here's Why

Oct 28, 2024, 3:06 PM EDT - 1 year ago

This Biotech Stock Has Doubled Its Value Today—Here's Why


Monte Rosa Therapeutics Announces Leadership Team Promotions

May 30, 2024, 7:00 AM EDT - 1 year ago

Monte Rosa Therapeutics Announces Leadership Team Promotions


juice_rock
juice_rock Jan. 30 at 5:50 PM
$GLUE About 82% institutional owned and almost 100% long. https://fintel.io/so/us/glue I see every reason to continue holding long term.
0 · Reply
LabPsycho
LabPsycho Jan. 28 at 3:57 PM
$GLUE @dylirious CEOs selling rarely is a good look. But I will give him a pass due to 500% gain in the stock in a few months and closing a great deal. But it , plus the large offering likely will put a damper on the stock and suggests to me nothing major is going to unfold in the next few months. I expect the stock to do a significant retrace before possibly climbing to $30 but that's many months away and a lot will happen in the overall market before then is my guess. As I have posted before I am thinking GLUE could be between 10 and 30 over the next year. The "executive sells are predetermined" is a great argument investors use to gaslight themselves to ignore the likely future trend of the stock. Good luck
0 · Reply
juice_rock
juice_rock Jan. 26 at 4:20 PM
$GLUE Will continue holding. $1.75 Billion market cap with $10 Billion in signed agreements upon milestones. And the last two interims are good data.
0 · Reply
JFais
JFais Jan. 23 at 1:09 PM
This week in Chat: -A number of interesting setups shared in our Non-Biotech channel, including Crypto & Tokenization side of things -Good back and forth on $CRVS, quite a few people owned into the data (vs selling early like I did 🤦‍♂️). Implications for evolving atopic dermatitis landscape & increased market penetration estimates (IF data holds up in higher N of patients). Not to mention impact on confidence level into pivotal PTCL readout and potential to soon move forward in expansion indications like asthma & HS). IP to 2042= long-lived per CEO but others think it's only to 2037 (plenty of time to develop soquelitinib in other indications as well as move next-gen ITK inhibitors forward) Also, noteworthy discussions in $GLUE, $CELC, $VIR, $AVBP among others
0 · Reply
oneyedjacks
oneyedjacks Jan. 22 at 8:52 PM
$GLUE Low volume day, but damn
0 · Reply
MuchMillions
MuchMillions Jan. 22 at 7:21 PM
$GLUE most likely sideways until the conference late February
0 · Reply
nbkihy8
nbkihy8 Jan. 22 at 3:54 PM
$GLUE I'm expecting the next leg up will happen these next few weeks. Prepare for $30 plus
0 · Reply
JFais
JFais Jan. 21 at 9:37 PM
Speaking of missed binaries $WVE $CRVS As well as blow-ups or stocks that ran without us (seeing $GLUE & $ERAS among those currently discussed in Chat) Was one reason I recorded video below (too many ppl being too hard on themselves vs simply live & learn, apply going forward)
0 · Reply
oneyedjacks
oneyedjacks Jan. 21 at 7:28 PM
$GLUE can anyone see this beyond the pay wall?1 https://finance.yahoo.com/m/03c3bd97-33c1-3e5b-b7d1-ef399f0928fc/staar-surgical-alumis-and.html
0 · Reply
Eroc
Eroc Jan. 21 at 3:54 PM
$GLUE I'm ready for the next leg up! Let's go bulls!
0 · Reply
MuchMillions
MuchMillions Jan. 21 at 2:34 PM
0 · Reply
oneyedjacks
oneyedjacks Jan. 20 at 8:02 PM
$GLUE Time to restart the climb
0 · Reply
Eroc
Eroc Jan. 20 at 6:19 PM
$VWAV wow! many of my tickers did very nice recoveries today after looking dismall like $VWAV this morning. Check out $SIDU, $INSP , $LW , and $GLUE were some of the ones with more drastic dips at the open. But hey, it's all good now. Let's go bulls!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 20 at 2:20 AM
$GLUE RSI: 69.91, MACD: 2.2885 Vol: 4.10, MA20: 19.24, MA50: 16.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Emtb
Emtb Jan. 19 at 6:02 PM
$GLUE They're going to fill that gap
1 · Reply
SannieVerraderlijk
SannieVerraderlijk Jan. 15 at 9:26 PM
$GLUE Been sniffing more GLUE today, this is a giant in the making
1 · Reply
anachartanalyst
anachartanalyst Jan. 14 at 3:02 PM
$GLUE https://anachart.com/wp-content/uploads/ana_temp/1768402894_soc-img.jpg
0 · Reply
PresentBiden
PresentBiden Jan. 14 at 2:33 PM
$GLUE fucccc
0 · Reply
PresentBiden
PresentBiden Jan. 14 at 2:33 PM
$GLUE who is this?????
0 · Reply
PresentBiden
PresentBiden Jan. 13 at 8:37 PM
1 · Reply
Newtothisting
Newtothisting Jan. 13 at 1:42 PM
$GLUE why hasn't this shit tanked yet, smh too many close term puts
1 · Reply
Holdyn_Baggins
Holdyn_Baggins Jan. 13 at 12:05 PM
$GLUE what’s the matter they can’t close the deal at this inflated price? I’m shocked. This SP is TOO DAMN HIGH!
1 · Reply